戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1746143作成日:2026年10月25日

Hydrazine → Oxadiazole

https://huagongshe.com/reaction/1746143

反応式

関与物質

役割名称HCID仕込み量
反応物HydrazineHCID 9321—
反応物Ethyl orthoformateHCID 31214—
反応物Methyl 5-hydroxypyridine-3-carboxylateHCID 354317—
反応物3-Bromo-1,2-oxazoleHCID 13933891—
溶媒MethanolHCID 887—
溶媒WaterHCID 962—
溶媒Ethyl AcetateHCID 8857—
生成物OxadiazoleHCID 10197612—
生成物3-(Pyridin-3-yloxy)-4,5-dihydroisoxazoleHCID 66818532—

反応手順

3-(pyridin-3-yloxy)-4,5-dihydroisoxazole I-228a and I-228b were prepared in 3 steps according to the following procedures: 5-hydroxynicotinic acid methyl ester is reacted with racemic bromoisoxazole I-75 using Method 5. The resulting methyl ester (1.0 equiv) is dissolved in methanol (0.08 M) after which hydrazine (50 equiv, 50% by weight in water) is added and the reaction is allowed to stir for 14 h. The reaction mixture is then concentrated under vacuum and used directly in the next step. Triethylorthoformate (8.0 equiv) is added and the reaction is sealed and heated to reflux for 14 h. The reaction is then transferred to a separatory funnel with excess ethyl acetate and water. The organic layer was washed water and brine, drive over sodium sulfate and concentrated under vacuum to provide crude material which was purified using flash silica gel chromatography (gradient ethyl acetate/hexanes) to provide the desired racemic oxadiazole I-228. These compounds can be separated using chiral HPLC methods known in the art. For example, see chiral HPLC Method disclosed herein. [M+H]+=407.5 m/z. Activity: A

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US09149465B2
出典データセットuspto-grants-2015_10
ORD IDord-ca6e29a8d6c749a7bc5a1dc6435a30d2
出典メモuspto-grants-2015_10